Form 4: Allovir Inc. Executive Hagen Sells Shares to Cover Tax Obligations

Brett Hagen, Chief Accounting Officer of Allovir, Inc., sold shares of common stock on January 23, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On January 23, 2025, Brett Hagen, the Chief Accounting Officer of Allovir, Inc., sold shares of the company's common stock.
• The sales were executed in two transactions at weighted average prices of $9.4538 and $9.9402.
• A total of 36 shares were sold.
• These sales were conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• The reporting person does not have discretion over these sales as they are automatic.
• The transactions reflect a 1-for-23 reverse stock split that took place on January 16, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales for tax purposes, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock sale by an officer could have a minor impact on shareholder sentiment, though it's primarily driven by tax obligations.

Key Dates